Skip to content

LSD: all studies

Page 201 of 282: studies 2,001 to 2,010 of 2,815, newest first. Back to the LSD overview

Research

Psychedelics promote plasticity by directly binding to BDNF receptor TrkB

Nature Neuroscience June 1, 2023 Rafael Moliner, Mykhailo Girych, Vera Kovaleva et al. 439 citations

Abstract Psychedelics produce fast and persistent antidepressant effects and induce neuroplasticity resembling the effects of clinically approved antidepressants. We recently reported that pharmacologically diverse antidepressants, including fluoxetine and ketamine, act by binding to TrkB, the receptor for BDNF. Here we show that lysergic acid diethylamide (LSD) and psilocin directly bind to...

DOI: 10.1038/s41593-023-01316-5 (opens in new tab) Full text (opens in new tab) Neuroplasticity Brain-derived neurotrophic factor Receptor Neurotrophic factors

The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs.

Psychedelic Medicine June 1, 2023 Stephanie Lake, Philippe Lucas 30 citations

Recent years have seen a resurgence in clinical interest in, and increased public acceptance of, psychedelic drugs in Canada. However, our understanding of how psychedelic drugs are currently used in Canada remains limited. We developed the Canadian Psychedelic Survey (CPS) to gather real-world evidence about psychedelic drug use in Canada. This study aimed to characterize CPS respondents;...

DOI: 10.1089/psymed.2023.0002 (opens in new tab) Full text (opens in new tab) Canada Psychedelics research Mental health treatment Substance use survey +2

In utero exposure to ADHD drugs not linked to developmental disorders

The Brown University Psychopharmacology Update May 28, 2023

expected the microdosing to change how they felt on measures of 18 affective states: angry, anxious, calm, cognitive functioning, craving, creative, connected, energy, focused, guilty, happy, meditative, motivated, open, sad, self-efficacy, stressed, and well. They were asked at the final visit to report whether microdosing actually did result in change in these states. Data on adverse events...

Henri Michaux's program for the psychedelic humanities

Frontiers in Psychology May 16, 2023 Oliver Davis 4 citations

This article presents an analytical reading of the extraordinarily rich cultural production around drugs by the 20th-century French poet, writer, critic, and visual artist Michaux (1899–1984). Over about a decade, from the mid-1950's, the otherwise habitually sober Michaux wrote five books, included within which were dozens of drawings, and made one half-hour film, charting his adventures as an...

THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE

PARIPEX INDIAN JOURNAL OF RESEARCH May 15, 2023 Chirag Ambaliya, Dimple Gupta, Ashok Vala et al.

The purpose of this review article is to give a summary of the literature on the use of psychedelic drugs, such as psilocybin, LSD, ayahuasca, and MDMA, in the treatment of various mental health conditions, such as depression, anxiety, PTSD, and substance use disorders. This review's main goal is to highlight recent human studies on the use of particular psychedelic drugs, like psilocybin, LSD,...

Microbiome–Gut–Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders

ACS Medicinal Chemistry Letters May 11, 2023 Robert B. Kargbo 15 citations

The gut-brain axis (GBA) refers to the sophisticated bidirectional communication system connecting the digestive system with the central nervous system. This interaction is enabled by a series of intricate signaling processes, encompassing various neuro-immune and hormonal pathways. The association between the gut microbiome and mental health has garnered immense scientific and public interest,...

DOI: 10.1021/acsmedchemlett.3c00168 (opens in new tab) Full text (opens in new tab) Gut–brain axis Gut microbiome Lysergic acid Enteric nervous system +1

Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis

Cureus May 7, 2023 Suhwoo Bae, Michael Vaysblat, Ilja Dejanovic et al. 6 citations

Recreational drug use is a significant public health concern in various countries. It is well understood that usage of psychedelics/hallucinogens, such as lysergic acid diethylamide (LSD), ecstasy, phencyclidine (PCP), and psilocybin-containing mushrooms, has increased significantly over the last few decades, particularly in adolescents and young adults, yet the effects of these recreational...

A whole-brain model of the neural entropy increase elicited by psychedelic drugs.

Scientific Reports April 17, 2023 Rubén Herzog, Pedro A. M. Mediano, Fernando E. Rosas et al. 51 citations

Psychedelic drugs, including lysergic acid diethylamide (LSD) and other agonists of the serotonin 2A receptor (5HT2A-R), induce drastic changes in subjective experience, and provide a unique opportunity to study the neurobiological basis of consciousness. One of the most notable neurophysiological signatures of psychedelics, increased entropy in spontaneous neural activity, is thought to be of...

Benzydamine-An Affordable Over-the-Counter Drug with Psychoactive Properties-From Chemical Structure to Possible Pharmacological Properties.

Pharmaceuticals April 10, 2023 Bianca-Eugenia Ősz, George Jîtcă, Andreea Sălcudean et al. 29 citations

Benzydamine is a non-steroidal anti-inflammatory drug with distinct pharmacological properties from other compounds in the same therapeutic class. The differences are structural and pharmacological in nature; the anti-inflammatory mechanism is not strictly explained by the ability to interfere with the synthesis of prostaglandins. The compound is used strictly in local inflammatory diseases...

DOI: 10.3390/ph16040566 (opens in new tab) Full text (opens in new tab) Benzydamine Inflammation Neuropathic pain Over the counter +6

Gli psichedelici: quanto è efficace e sicuro il loro possibile impiego in psichiatriae psicoterapia? Lo stato delle evidenze

PNEI REVIEW April 1, 2023 Francesco Dente

Nell'ultimo decennio la ricerca sull'utilizzo terapeutico degli psichedelici ha subito un'impennata, soprattutto per quanto riguarda la loro poten- ziale applicazione nel trattamento dei disturbi psichiatrici. In questi studi è stata indagata la sicurezza e l'efficacia delle varie sostanze psichedeliche, come gli psichedelici classici (psilocibina, ayahuasca e LSD) la ketamina e l'MDMA. Gli...